The road not taken: Exploring non-transplant options in De Novo philadelphia positive acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease with diverse molecular cytogenetic characteristics. Philadelphia-positive acute myeloid leukemia, a rare subtype of AML, is traditionally considered a high-risk, with the standard recommendation being an allogeneic hematopoietic cell transplant...
Saved in:
| Main Authors: | Mohamed I Sharif, Ahmad S. Alotaibi, Ruah Alyamany, Ali Alahmari, Hanan Alkhaldi, Ayman Saad, Mansour Alfayez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Leukemia Research Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048925000093 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE ROAD NOT-TAKEN: EXPLORING NON-TRANSPLANT OPTIONS IN DE NOVO PHILADELPHIA - POSITIVE ACUTE MYELOID LEUKEMIA
by: Mohamed Sharif, et al.
Published: (2025-07-01) -
Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation
by: Yasutaka Sadaga, et al.
Published: (2025-12-01) -
Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies
by: Tomasz Sacha, et al.
Published: (2025-01-01) -
The remarkable response to ponatinib therapy in a child with blastic phase of chronic myeloid leukemia
by: Tekin Aksu, et al.
Published: (2020-06-01) -
Treatment of minimal residual disease in myeloid malignancies after allo-HSCT with venetoclax-based regimens in patients ineligible for or failed in the immunotherapy
by: Wen-Jing Yu, et al.
Published: (2024-12-01)